Business
Abeona Therapeutics® Announces Date of Fourth Quarter / Full Year 2025 Financial Results and Participation in Upcoming 2026 Leerink Global Healthcare Conference
CLEVELAND, March 03, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it will host a conference call on Tuesday, March 17, 2026 at 8:30 a.m. ET to discuss its fourth quarter and full year 2025 financial results and corporate progress. The conference call will be available via phone and webcast. To access the call, dial 888-506-0062 (U.S. toll-free) or 973-528-0011 (international) and Entry Code: 977217 five minutes prior to the start of the call. A live, listen-on
About this update from Abeona Therapeutics Inc.
[{"type":"image","alt":"Abeona Therapeutics Inc.","displaySize":"","headline":null,"caption":"Abeona Therapeutics Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":256,"height":181,"url":"https://media.zenfs.com/en/globenewswire.com/29420b6ac7ca8949eb7c2a775811595d"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/qj_IDTqo2_8aVBxsha_Qwg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTI5NztjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/29420b6ac7ca8949eb7c2a775811595d","width":256,"height":181}},"lazy":false},{"type":"text","content":"CLEVELAND, March 03, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it will host a conference call on Tuesday, March 17, 2026 at 8:30 a.m. ET to discuss its fourth quarter and full year 2025 financial results and corporate progress.","length":266,"tagName":"p"},{"type":"text","content":"The conference call will be available via phone and webcast. To access the call, dial 888-506-0062 (U.S. toll-free) or 973-528-0011 (international) and Entry Code: 977217 five minutes prior to the start of the call. A live, listen-only webcast and archived replay of the call can be accessed on the Investors & Media section of Abeona’s website at https://investors.abeonatherapeutics.com/events. The archived webcast replay will be available for 30 days following the call.","length":478,"tagName":"p"},{"type":"text","content":"Participation in 2026 Leerink Global Healthcare ConferenceAbeona management will participate in a fireside chat at the 2026 Leerink Global Healthcare Conference on Tuesday, March 10, 2026 at 8:40 a.m. Eastern Time. A live webcast of the fireside chat can be accessed on the Investors section of the Abeona website under "Events" at https://investors.abeonatherapeutics.com/events. The webcast will be archived for 30 days.","length":434,"tagName":"p"},{"type":"text","content":"About Abeona Therapeutics Abeona Therapeutics Inc. is a commercial-stage biopharmaceutical company developing cell and gene therapies for serious diseases. Abeona’s ZEVASKYN® (prademagene zamikeracel) is the first and only autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The Company’s fully integrated cell and gene therapy cGMP manufacturing facility in Cleveland, Ohio serves as t...